Acid reflux drugs linked to nasty tummy bugs


Tuesday, 10 January, 2017


Acid reflux drugs linked to nasty tummy bugs

Use of stomach acid suppressing drugs, one of which is the second most prescribed drug in Australia, has been linked to an increased risk in gastro bugs and gut infections, UK researchers say. The study found that taking acid suppression medications put people at almost twice the risk of developing a C. difficile infection and almost four times the risk of developing a Campylobacter infection.

In the population-based study from Scotland, use of commonly prescribed acid suppression medications such as proton pump inhibitors (PPIs) was linked with the increased risk of intestinal infections with C. difficile and Campylobacter bacteria, which can cause considerable illness.

Compared with individuals in the community who did not take acid suppression medications, those who did had 1.7 times and 3.7 times increased risks of C. difficile and Campylobacter, respectively. Among hospitalised patients, those using the medications had 1.4 times and 4.5 times increased risks, respectively.

Although acid suppression therapy is often considered relatively free from side effects, the findings suggest that there are significant adverse gastrointestinal consequences of their use.

“Users of these medications should be particularly vigilant about food hygiene as the removal of stomach acid makes them more easily infected with agents such as Campylobacter, which is commonly found on poultry,” said Prof. Thomas MacDonald, senior author of the British Journal of Clinical Pharmacology study.

Reference: Li Wei et al. Acid suppression medications and bacterial gastroenteritis: a population-based cohort study. BJCP, 5 January 2017.

Related Articles

GenesisCare expands with $35m Northern Beaches cancer centre

The relocated centre has expanded its services with a new radiation therapy offering and access...

In Conversation with Royal Women's Hospital CEO Sue Matthews

An hour after the final call for visitors to leave, Professor Sue Matthews — now CEO of...

Global prostate cancer rates predicted to double by 2040

The number of annual prostate cancer deaths worldwide is predicted to rise by 85% from 375,000 in...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd